scholarly journals Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice

Hepatology ◽  
2004 ◽  
Vol 40 (6) ◽  
pp. 1322-1332 ◽  
Author(s):  
Eyal Shteyer ◽  
Yunjun Liao ◽  
Louis J. Muglia ◽  
Paul W. Hruz ◽  
David A. Rudnick
2010 ◽  
Vol 48 (01) ◽  
Author(s):  
ER Almajan ◽  
R Sandhoff ◽  
MC Gonzales ◽  
R Büttner ◽  
S Weber ◽  
...  

2009 ◽  
Vol 50 ◽  
pp. S313
Author(s):  
V. Lowin ◽  
J.M. Schattenberg ◽  
M.F. Sprinzl ◽  
T. Zimmermann ◽  
P.R. Galle ◽  
...  

1998 ◽  
Vol 95 (23) ◽  
pp. 13829-13834 ◽  
Author(s):  
R. M. Rai ◽  
F. Y. J. Lee ◽  
A. Rosen ◽  
S. Q. Yang ◽  
H. Z. Lin ◽  
...  

Hepatology ◽  
2007 ◽  
Vol 46 (1) ◽  
pp. 229-241 ◽  
Author(s):  
Ian N. Hines ◽  
Michael Kremer ◽  
Fuyumi Isayama ◽  
Ashley W. Perry ◽  
Richard J. Milton ◽  
...  

2008 ◽  
Vol 393 (3) ◽  
pp. 325-332 ◽  
Author(s):  
Daniel Seehofer ◽  
Ulf P. Neumann ◽  
Anja Schirmeier ◽  
Jessica Carter ◽  
Si-Young Ria Cho ◽  
...  

2003 ◽  
Vol 198 (6) ◽  
pp. 913-923 ◽  
Author(s):  
Christoph W. Strey ◽  
Maciej Markiewski ◽  
Dimitrios Mastellos ◽  
Ruxandra Tudoran ◽  
Lynn A. Spruce ◽  
...  

Complement has been implicated in liver repair after toxic injury. Here, we demonstrate that complement components are essential for liver regeneration, and mediate their effect by interacting with key signaling networks that promote hepatocyte proliferation. C3- or C5-deficient mice exhibited high mortality, parenchymal damage, and impaired liver regeneration after partial hepatectomy. Mice with dual C3 and C5 deficiency had a more exacerbated phenotype that was reversed by combined C3a and C5a reconstitution. Interception of C5a receptor signaling resulted in suppression of IL-6/TNFα induction and lack of C3 and C5a receptor stimulation attenuated nuclear factor–κB/STAT-3 activation after hepatectomy. These data indicate that C3a and C5a, two potent inflammatory mediators of the innate immune response, contribute essentially to the early priming stages of hepatocyte regeneration.


2008 ◽  
Vol 26 (11) ◽  
pp. 1836-1842 ◽  
Author(s):  
George Van Buren ◽  
Anthony D. Yang ◽  
Nikolaos A. Dallas ◽  
Michael J. Gray ◽  
Sherry J. Lim ◽  
...  

Purpose Unresectable metastatic colorectal cancer (CRC) can be rendered resectable with systemic chemotherapy in approximately 20% of cases. Most patients with metastatic CRC receive chemotherapy with the addition of targeted therapy with anti–vascular endothelial growth factor (VEGF) or anti–epidermal growth factor receptor (EGFR) antibodies. We sought to determine whether anti-VEGF receptor (VEGFR) or anti-EGFR therapy would impair liver regeneration after partial hepatectomy (PH) in mice. Materials and Methods Mice underwent either 66% PH or sham laparotomy. In the first experiment, mice in the PH group were randomly assigned to receive daily intraperitoneal injections of monoclonal antibodies (MoABs) to murine VEGFR-2 or nonspecific MoABs (control). In the second experiment, mice in the PH group were randomly assigned to receive intraperitoneal injections of antimurine EGFR or nonspecific (control) MoABs. In both experiments, therapy was initiated the day before surgery and continued until the mice were killed on day 5. Livers were collected and processed. Results Anti–VEGFR-2 therapy slightly impaired liver regeneration and hepatic cell proliferation compared with control. Hematoxylin and eosin staining showed no differences in liver morphology. CD105 staining showed decreased levels of activated endothelium in livers in the VEGFR-2 MoAB group. VEGFR-2 MoAB therapy decreased the levels of the cell cycle regulators cyclin D1 and cyclin D3 and the regenerative cytokine interleukin-6. Anti-EGFR therapy had no effect on liver regeneration or cellular proliferation. Conclusion Anti–VEGFR-2 therapy slightly impaired liver regeneration in this murine model, whereas anti-EGFR therapy had no effect on liver regeneration.


Sign in / Sign up

Export Citation Format

Share Document